Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Non-Current Liabilities: 2019-2024

Historic Other Non-Current Liabilities for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to $815,000.

  • Biodesix's Other Non-Current Liabilities rose 24.03% to $769,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $769,000, marking a year-over-year increase of 24.03%. This contributed to the annual value of $815,000 for FY2024, which is 14.47% up from last year.
  • Per Biodesix's latest filing, its Other Non-Current Liabilities stood at $815,000 for FY2024, which was up 14.47% from $712,000 recorded in FY2023.
  • Biodesix's 5-year Other Non-Current Liabilities high stood at $29.9 million for FY2020, and its period low was $712,000 during FY2023.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $815,000 (2024), whereas its average is $6.7 million.
  • Per our database at Business Quant, Biodesix's Other Non-Current Liabilities rose by 16.33% in 2022 and then plummeted by 96.18% in 2023.
  • Biodesix's Other Non-Current Liabilities (Yearly) stood at $29.9 million in 2020, then plummeted by 46.45% to $16.0 million in 2021, then grew by 16.33% to $18.6 million in 2022, then plummeted by 96.18% to $712,000 in 2023, then grew by 14.47% to $815,000 in 2024.